How Our Studies Work

Parent-To-Be Enrolls in Study 

We Gather Info about the Pregnancy 

Discoveries & Insights Gained 

What is a MotherToBaby Pregnancy Study?

MotherToBaby Pregnancy Studies is a research program seeking to understand how certain medications, vaccines, or health conditions may affect pregnancy. Our research will help people who are pregnant and/or breastfeeding and health providers make informed treatment decisions. All of our studies are observational: we will never ask someone to take or change any aspect of their current health routine.

Who Leads MotherToBaby Pregnancy Studies?

Christina Chambers, PhD, MPH is the lead investigator for MotherToBaby Pregnancy Studies, which are coordinated by UC San Diego’s Center for Better Beginnings. She is a world‐renowned perinatal epidemiologist and a Professor of Pediatrics and Family and Preventive Medicine at the UC San Diego. Her interests are in the areas of birth defects and other pregnancy outcomes, with a special focus on exposures that can cause birth defects.

“Every person deserves to know if their health conditions or the medication they need to take could affect their baby during pregnancy. We are committed to bringing you better information for healthier outcomes.”

– Christina Chambers, PhD, MPH

If you are interested in joining the study, please submit your interest below. Our research team will contact you to see if you qualify. Your information is confidential.

If you are a health professional, please fill out the Refer a Patient form and we will contact your patient to see if they qualify. Your information is confidential.

The post BOOSTRIX Tdap Vaccine appeared first on MotherToBaby.

How Our Studies Work

Parent-To-Be Enrolls in Study 

We Gather Info about the Pregnancy 

Discoveries & Insights Gained 

What is a MotherToBaby Pregnancy Study?

MotherToBaby Pregnancy Studies is a research program seeking to understand how certain medications, vaccines, or health conditions may affect pregnancy. Our research will help people who are pregnant and/or breastfeeding and health providers make informed treatment decisions. All of our studies are observational: we will never ask someone to take or change any aspect of their current health routine.

Who Leads MotherToBaby Pregnancy Studies?

Christina Chambers, PhD, MPH is the lead investigator for MotherToBaby Pregnancy Studies, which are coordinated by UC San Diego’s Center for Better Beginnings. She is a world‐renowned perinatal epidemiologist and a Professor of Pediatrics and Family and Preventive Medicine at the UC San Diego. Her interests are in the areas of birth defects and other pregnancy outcomes, with a special focus on exposures that can cause birth defects.

“Every person deserves to know if their health conditions or the medication they need to take could affect their baby during pregnancy. We are committed to bringing you better information for healthier outcomes.”

– Christina Chambers, PhD, MPH

If you are interested in joining the study, please submit your interest below. Our research team will contact you to see if you qualify. Your information is confidential.

If you are a health professional, please fill out the Refer a Patient form and we will contact your patient to see if they qualify. Your information is confidential.

The post Kesimpta® (ofatumumab) (US PATIENTS ONLY) appeared first on MotherToBaby.

How Our Studies Work

Parent-To-Be Enrolls in Study 

We Gather Info about the Pregnancy 

Discoveries & Insights Gained 

What is MotherToBaby Pregnancy Studies?

MotherToBaby Pregnancy Studies is a research program seeking to understand how certain medications, vaccines, or health conditions may affect pregnancy. Our research will help people who are pregnant and/or breastfeeding and health providers make informed treatment decisions. All of our studies are observational: we will never ask someone to take or change any aspect of their current health routine.

Who Leads MotherToBaby Pregnancy Studies?

Christina Chambers, PhD, MPH is the lead investigator for MotherToBaby Pregnancy Studies, which are coordinated by UC San Diego’s Center for Better Beginnings. She is a world‐renowned perinatal epidemiologist and a Professor of Pediatrics and Family and Preventive Medicine at the UC San Diego. Her interests are in the areas of birth defects and other pregnancy outcomes, with a special focus on exposures that can cause birth defects.

“Every person deserves to know if their health conditions or the medication they need to take could affect their baby during pregnancy. We are committed to bringing you better information for healthier outcomes.”

– Christina Chambers, PhD, MPH

The post Mayzent® (siponimod) (US PATIENTS ONLY) appeared first on MotherToBaby.

MotherToBaby is currently enrolling participants into an observational study examining the use of Adbry® (tralokinumab-ldrm) when taken during pregnancy. Our research is by observation only—we will not ask you to take or change any medications. If you join our Adbry® (tralokinumab-ldrm) study, our team will simply collect some information about your pregnancy and your baby’s development for a period of time after birth. 

“Help us improve the ability for pregnant people and their healthcare providers to make more informed treatment decisions by joining our Adbry® (tralokinumab-ldrm) & pregnancy study.”

— Christina Chambers, PhD, MPH, Lead Investigator, MotherToBaby Pregnancy Studies

Our study includes:
• 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
• Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.
• An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor
• A neurodevelopmental assessment that can also provide insight into the child’s development at approximately 4 months and 12 months of age

If you have moderate-to-severe eczema (atopic dermatitis) and have taken Adbry® (tralokinumab-ldrm) at any point in your current pregnancy or 3 months prior to pregnancy, you may qualify for this important study.

Will you take the next step and help us learn more about the use of Adbry® (tralokinumab-ldrm) during pregnancy?

The post Adbry® (tralokinumab-ldrm) appeared first on MotherToBaby.

Many pregnant people with systemic lupus erythematosus (or SLE, a type of lupus) will have healthy babies. However, some people experience complications. With your help, we can capture more information about how lupus can affect pregnancy.

“Our observational research program collects important information about lupus and its treatment during pregnancy. This information will be used by healthcare providers and future parents to better manage lupus during pregnancy.”

— Christina Chambers, PhD, MPH, Lead Investigator, MotherToBaby Pregnancy Studies

Our lupus study includes:

• 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
• Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.
• An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor

You can help us better understand lupus and its treatment in pregnancy. Will you become our partner and join the Lupus & Pregnancy Study?

The post Lupus appeared first on MotherToBaby.

MotherToBaby is currently enrolling participants into an observational study examining the use of Benlysta® (belimumab) for systemic lupus erythematosus (or SLE, a type of lupus) or active lupus nephritis (lupus-related kidney inflammation) when taken during pregnancy. Our research is by observation only—we will not ask you to take or change any medications. If you join our Benlysta® study, our team will simply collect some information about your pregnancy and your baby’s development for a period of time after birth.

“Help us improve the ability for pregnant people and their healthcare providers to make safe treatment decisions by joining our Benlysta® & Pregnancy study.”

— Christina Chambers, PhD, MPH, Lead Investigator, MotherToBaby Pregnancy Studies

Our Benlysta® study includes:

• 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
• Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.
• An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor

If you have lupus and have taken Benlysta® at any point in your current pregnancy or 3 months prior to pregnancy, you may qualify for this important study.

Will you take the next step and help us learn more about the use of Benlysta® during pregnancy?

The post Benlysta® (belimumab) appeared first on MotherToBaby.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Stelara® (ustekinumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Orencia® (abatacet) (NO LONGER ENROLLING) appeared first on MotherToBaby.

Since COVID-19 mRNA vaccines (Pfizer-BioNTech or Moderna) became available, we’ve been enrolling pregnant people who received the vaccine into an observational study. The study has helped provide critical information to future moms-to-be and the medical community about the use of these vaccines during pregnancy. But there’s more to learn!

We’re currently looking for people who received a dose of a COVID-19 mRNA vaccine in the last 2 months while they were pregnant.

This study involves:

• 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
• Providing a blood sample at a lab near you. We will use this to study how your immune system responds to the vaccine.
• Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.

“By sharing your pregnancy with us, you are helping us answer important questions about COVID-19 mRNA vaccines in pregnancy. The answers to these questions can help future moms-to be.”

— Christina Chambers, PhD, MPH,
UC San Diego Center for Better Beginnings,
Lead Investigator, MotherToBaby Pregnancy Studies

Have you received a COVID-19 vaccine in the last 2 months? Were you pregnant at that time, and are you still pregnant now? If you answered “yes” to these questions, then you can help us gather important information about the use of COVID-19 vaccines in pregnancy. Join our study today!

The post COVID-19 mRNA Vaccines appeared first on MotherToBaby.

Many people need to take medication during pregnancy to appropriately manage a chronic health condition. In some cases, avoiding or stopping medication use during pregnancy may be more harmful than taking medication. Yet fewer than 10% of medications have enough information to determine their safety for use in pregnancy — this is where you come in!

MotherToBaby is currently enrolling people who are pregnant in a study examining the use of Motegrity® (prucalopride) to treat functional constipation during pregnancy.

“There is a huge need to generate more data for all of the drugs that people who are pregnant need to take.”

— Christina Chambers, PhD, MPH, Lead Investigator, MotherToBaby Pregnancy Studies

Are you currently pregnant? Did you take Motegrity® at any point in your current pregnancy? If you answered “yes” to both of these questions, then you have the opportunity to help us learn more about Motegrity® use in pregnancy.

Will you take the step and become our partner? Make an impact on the health of future families today by joining our Motegrity® & Pregnancy Study!

The post Motegrity® (prucalopride) appeared first on MotherToBaby.